[ad_1]
Editor’s be aware: This text has been up to date with extra context from Heal.
Heal, a home-based main care and telehealth firm, is planning layoffs forward of a possible sale.
In keeping with WARN notices, Heal would lower 182 jobs in Los Angeles County and 60 positions in New York Metropolis. An organization spokesperson informed MobiHealthNews the corporate is in energetic discussions with potential patrons, and it is required to file notices in New York and California relating to potential upcoming layoffs.
In late October, Heal introduced it could increase with Cigna Medicare Benefit members in Georgia, Illinois, North Carolina and South Carolina. The startup most lately raised $100 million from insurer Humana in 2020.
Heal’s layoffs mark the most recent in a spate of job cuts at digital well being firms. Earlier this month, digital behavioral well being firm SonderMind laid off 15% of its workers, not lengthy after it introduced the acquisition of Complete Mind.
Different digital well being corporations which have lately made cuts embody Headspace Well being, Komodo Well being and OneStudyTeam.
Quris, a software program firm that makes use of AI to foretell viable drug candidates, raised $9 million in seed funding, bringing its whole increase to $37 million.
The spherical was led by SoftBank Imaginative and prescient Fund 2 with present institutional and personal buyers, together with iAngels, Richter Group, Welltech Ventures and GlenRock Capital.
In January, Quris garnered $28 million in its preliminary seed-funding spherical.
The corporate makes use of its Bio-AI Scientific Prediction Platform to check the protection of medication through its Sufferers-on-a-Chip system, which mixes evaluation from stem-cell tissues and AI to simulate an individual’s response to a drug.
The brand new funding will assist the corporate develop its crew, advance its platform, construct business collaborations and speed up its analysis.
“We imagine the early forecasting functionality that Quris is growing brings actual potential impression to the worldwide pharmaceutical business,” Yossi Cohen, director of Israel operations for SoftBank Funding Advisers, stated in an announcement. “Harnessing the novel utility of AI, Dr. Bentwich and his crew may save the big prices of medication failing in scientific trials, and in doing so create a enterprise in Israel of great financial worth.”
Boston-based PharmStars, a pharma-focused digital well being accelerator, introduced that it is accepting purposes for its fourth cohort.
The spring 2023 digital program will give attention to digital well being options from world wide that tackle girls’s well being circumstances, and circumstances the place girls are disproportionately affected or have worse outcomes. PharmStars may also contemplate digital improvements that tackle well being inequities for underserved populations and that promote equitable, inclusive healthcare.
Launched in 2021, PharmStars focuses on educating well being tech firms and pharma about working collectively. It offers mentoring to digital well being startups seeking to interact with pharma and biotech firms.
The deadline for purposes for the spring 2023 cohort is January 14.
[ad_2]
Source link
